185 related articles for article (PubMed ID: 32228522)
1. HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study.
King C; Giang LM; Bart G; Kunkel L; Korthuis PT
BMC Public Health; 2020 Mar; 20(1):421. PubMed ID: 32228522
[TBL] [Abstract][Full Text] [Related]
2. HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial.
Korthuis PT; King C; Cook RR; Khuyen TT; Kunkel LE; Bart G; Nguyen T; Thuy DT; Bielavitz S; Nguyen DB; Tam NTM; Giang LM
Lancet HIV; 2021 Feb; 8(2):e67-e76. PubMed ID: 33539760
[TBL] [Abstract][Full Text] [Related]
3. Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam.
King C; Cook R; Giang LM; Bart G; Hoffman K; Waddell EN; Korthuis PT
J Subst Abuse Treat; 2022 Mar; 134():108451. PubMed ID: 33962813
[TBL] [Abstract][Full Text] [Related]
4. Familial support in integrated treatment with antiretroviral therapy and medications for opioid use disorder in Vietnam: A qualitative study.
Brown PCM; Dinh TTT; Edsall A; Nguyen TH; Mai PP; Hoffman K; Bart G; Korthuis PT; Le MG
Subst Abus; 2022; 43(1):1004-1010. PubMed ID: 35435799
[No Abstract] [Full Text] [Related]
5. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
[TBL] [Abstract][Full Text] [Related]
6. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
Altice FL; Bruce RD; Lucas GM; Lum PJ; Korthuis PT; Flanigan TP; Cunningham CO; Sullivan LE; Vergara-Rodriguez P; Fiellin DA; Cajina A; Botsko M; Nandi V; Gourevitch MN; Finkelstein R;
J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1(Suppl 1):S22-32. PubMed ID: 21317590
[TBL] [Abstract][Full Text] [Related]
7. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
Shrestha R; Copenhaver MM
Addict Behav; 2018 Oct; 85():88-93. PubMed ID: 29879611
[TBL] [Abstract][Full Text] [Related]
8. Health Care-Specific Enacted HIV-Related Stigma's Association with Antiretroviral Therapy Adherence and Viral Suppression Among People Living with HIV in Florida.
Algarin AB; Sheehan DM; Varas-Diaz N; Fennie KP; Zhou Z; Spencer EC; Cook RL; Morano JP; Ibanez GE
AIDS Patient Care STDS; 2020 Jul; 34(7):316-326. PubMed ID: 32639208
[TBL] [Abstract][Full Text] [Related]
9. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.
Low AJ; Mburu G; Welton NJ; May MT; Davies CF; French C; Turner KM; Looker KJ; Christensen H; McLean S; Rhodes T; Platt L; Hickman M; Guise A; Vickerman P
Clin Infect Dis; 2016 Oct; 63(8):1094-1104. PubMed ID: 27343545
[TBL] [Abstract][Full Text] [Related]
10. Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam.
Button D; Cook R; King C; Khuyen TT; Kunkel L; Bart G; Thuy DT; Nguyen DB; Blazes CK; Giang LM; Korthuis PT
Int J Drug Policy; 2022 Feb; 100():103503. PubMed ID: 34768124
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies.
Pham LT; Kitamura A; Do HM; Lai KA; Le NT; Nguyen VT; Kato M
Harm Reduct J; 2017 Feb; 14(1):12. PubMed ID: 28212645
[TBL] [Abstract][Full Text] [Related]
12. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
[TBL] [Abstract][Full Text] [Related]
13. Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and Vietnam.
Wagman JA; Wynn A; Matsuzaki M; Gnatienko N; Metsch LR; Del Rio C; Feaster DJ; Nance RM; Whitney BM; Delaney JAC; Kahana SY; Crane HM; Chandler RK; Elliott JC; Altice F; Lucas GM; Mehta SH; Hirsch-Moverman Y; El-Sadr WM; Vu Q; Nguyen Thanh B; Springer SA; Tsui JI; Samet JH
AIDS; 2020 Dec; 34(15):2285-2294. PubMed ID: 33048870
[TBL] [Abstract][Full Text] [Related]
14. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
15. Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic.
Simeone C; Shapiro B; Lum PJ
Addict Sci Clin Pract; 2017 Aug; 12(1):19. PubMed ID: 28826401
[TBL] [Abstract][Full Text] [Related]
16. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
[TBL] [Abstract][Full Text] [Related]
17. Use of methamphetamine and alcohol among people with opioid use disorder and HIV in Vietnam: a qualitative study.
Edsall A; Hoffman KA; Thuy DT; Mai PP; Hang NT; Khuyen TT; Trang NT; Kunkel LE; Giang LM; Korthuis PT
BMC Public Health; 2021 Sep; 21(1):1718. PubMed ID: 34548042
[TBL] [Abstract][Full Text] [Related]
18. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
[TBL] [Abstract][Full Text] [Related]
19. Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder.
Cook RR; Jaworski EN; Hoffman KA; Waddell EN; Myers R; Korthuis PT; Vergara-Rodriguez P
Subst Abus; 2023 Oct; 44(4):301-312. PubMed ID: 37842910
[TBL] [Abstract][Full Text] [Related]
20. Effects of incentives on viral suppression in people living with HIV who use cocaine or opiates.
Pollock S; Toegel F; Holtyn AF; Rodewald AM; Leoutsakos JM; Fingerhood M; Silverman K
Drug Alcohol Depend; 2020 Jul; 212():108000. PubMed ID: 32362436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
